ニュース
3 時間
Barchart on MSNThis Pharma Stock Is Still a ‘Strong Buy’ Despite Trump’s Plans to Lower Drug PricesWhile the early week buzz centered around the U.S.-China trade agreement, another critical development unfolded quietly but ...
Palantir defies bearish concerns with an asset-light model, and strong profitability backed by an 83% Rule of 40 score. Learn ...
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する